Clicky

Depression

2021 Major Depressive Disorder Pipeline Insight Report: Insights for Approx 50+ Companies and 50+ Pipeline Drugs – ResearchAndMarkets.com | Business

DUBLIN–(BUSINESS WIRE)–Jun 10, 2021– The “Major Depressive Disorder – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com‘s offering. This “Major Depressive Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Major Depressive Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical […]

2021 Major Depressive Disorder Pipeline Insight Report: Insights for Approx 50+ Companies and 50+ Pipeline Drugs – ResearchAndMarkets.com | Business Read More »

2021 Major Depressive Disorder Pipeline Insight Report: Insights for Approx 50+ Companies and 50+ Pipeline Drugs – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Major Depressive Disorder – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. This “Major Depressive Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Major Depressive Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It

2021 Major Depressive Disorder Pipeline Insight Report: Insights for Approx 50+ Companies and 50+ Pipeline Drugs – ResearchAndMarkets.com Read More »

How Your Phone Can Predict Depression and Lead to Personalized Treatment

According to the National Alliance on Mental Illness and the World Health Organization, depression affects 16 million Americans and 322 million people worldwide. Emerging evidence suggests that the COVID-19 pandemic is further exacerbating the prevalence of depression in the general population. With this trajectory, it is evident that more effective strategies are needed for therapeutics

How Your Phone Can Predict Depression and Lead to Personalized Treatment Read More »

Anger. Anxiety. Depression. Unprecedented Law School Admissions Cycle Is Taking a Mental Toll on Applicants

To call the current law school admissions cycle a rollercoaster is an understatement. The total number of applicants nationwide is up 17% and the number of people applying for fall 2021 with Law School Admission Test Scores of 170 or higher is up 65%, according to data from the Law School Admission Council. All of

Anger. Anxiety. Depression. Unprecedented Law School Admissions Cycle Is Taking a Mental Toll on Applicants Read More »

High depressive symptoms in previously undetected diabetes

Introduction The association between diabetes and prevalent depressive disorders has been frequently analyzed.1 Studies show an up to twofold higher prevalence of depressive disorders in persons with diabetes.1 Affected people who suffer from a combination of these two health problems have an increased mortality rate,2,3 risk of micro- and macro- vascular comorbidities4 as well as

High depressive symptoms in previously undetected diabetes Read More »

Laughing gas shows promise for treatment-resistant depression, small trial finds

Laughing gas has been used to dull pain in dental offices and maternity units for more than a century, and researchers now think the gas, called nitrous oxide, may effectively treat depression when other therapies have failed. That’s according to the results of a small phase 2 clinical trial, published Wednesday in the journal Science

Laughing gas shows promise for treatment-resistant depression, small trial finds Read More »

How Tara Davis overcame depression and injuries to become an Olympic gold medal contender – San Bernardino Sun

On the early evening of March 12, Texas junior Tara Davis raced down the long jump runway at the NCAA Indoor Track and Field Championships toward a leap a lifetime in the making. At Agoura High School she set U.S. Junior (Under 20) and national high school long jump records indoors and won a World

How Tara Davis overcame depression and injuries to become an Olympic gold medal contender – San Bernardino Sun Read More »

REL-1017 Shows Potential as a Frontline Depression Treatment

Dextromethadone (REL-1017) could become a top of the line treatment for patients with major depressive disorder (MDD). In data presented at American Psychiatric Association Virtual Meeting, a research team led by Maurizio Fava, MD, Psychiatrist-In-Chief, Department of Psychiatry, Massachusetts General Hospital, found the treatment was effective in reducing MADRS scores for patients with MDD. The

REL-1017 Shows Potential as a Frontline Depression Treatment Read More »